J. Attali

发表

Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications

P. Valensi, M. Belhadj, J. Pariés, 2010, Diabetic medicine : a journal of the British Diabetic Association.

Factors involved in cardiac autonomic neuropathy in diabetic patients.

P. Valensi, J. Attali, C. Giroux, 1997, Journal of diabetes and its complications.

Extra cellular water and increase in capillary permeability to albumin in overweight women with swelling syndrome

P. Valensi, J. Attali, D. Sandre-Banon, 2000, International Journal of Obesity.

High prevalence and severity of cardiac autonomic neuropathy in Vietnamese diabetic patients

P. Valensi, J. Pariés, J. Attali, 2005, Diabetic medicine : a journal of the British Diabetic Association.

Adrenocorticotropin-producing pituitary carcinoma with liver metastasis

M. Sibony, P. Valensi, P. Miossec, 1997, Journal of endocrinological investigation.

In vivo kinetics of 123 iodine-labelled insulin in skeletal muscle of patients with type 2 diabetes. Effect of metformin.

P. Valensi, N. Wiernsperger, J. Attali, 2002, Diabetes & metabolism.

Impairment of antidiuretic hormone and atrial natriuretic peptide regulation in the obese woman with a swelling syndrome and an increase in capillary permeability to albumin

P. Valensi, G. Perret, J. Attali, 1997, International Journal of Obesity.

The Effects of Metformin on the Capillary Permeability to Albumin in Women Patients with Cyclic Edema

P. Valensi, N. Wiernsperger, J. Attali, 1995, Angiology.

Increased capillary filtration of albumin in diabetic patients--relation with gender, hypertension, microangiopathy, and neuropathy.

P. Valensi, M. Attalah, J. Pariés, 1998, Metabolism: clinical and experimental.

Glucagon and noradrenaline reduce erythrocyte deformability.

P. Valensi, J. Attali, F. Gaudey, 1993, Metabolism: clinical and experimental.

[The "short Achilles tendon" syndrome: a new entity of the diabetic foot].

P. Valensi, P. Miossec, A. Fahed, 1997, Diabetes & metabolism.

Reproducibility of Parameters for Assessment of Diabetic Neuropathy

P. Valensi, J. Attali, S. Gagant, 1993, Diabetic medicine : a journal of the British Diabetic Association.

Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition.

P. Valensi, D. Koutsouris, J. Attali, 1990, Metabolism: clinical and experimental.

Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Chinese-French Scientific Committee for the Study of Diabetes.

M. Vray, J. Attali, 1995, Diabete & metabolisme.

Blood glucose changes and adjustments of diet and insulin doses in type 1 diabetic patients during scuba diving (for a change in French regulations).

P. Valensi, A. Tabah, A. Sola, 2005, Diabetes & metabolism.

Gonadal and adrenal catheterization during adrenal suppression and gonadal stimulation in a patient with bilateral testicular tumors and congenital adrenal hyperplasia.

M. Sibony, P. Valensi, M. Combes-Moukhovsky, 1994, The Journal of clinical endocrinology and metabolism.

EFFECT OF NIFEDIPINE ON THYROTROPIN, PROLACTIN, AND THYROID HORMONE RELEASE IN MAN: A PLACEBO‐CONTROLLED STUDY

P. Valensi, B. Uzzan, R. Vassy, 1989, Fundamental & Clinical Pharmacology.

Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation

P. Valensi, D. Lucas, J. Attali, 1998, Fundamental & clinical pharmacology.

Bone amyloidoma in a diabetic patient with morbid obesity.

P. Valensi, J. Amouroux, F. Arthuis, 1999, Diabetes & metabolism.

Markers for silent myocardial ischemia in diabetes. Are they helpful?

P. Valensi, E. Cosson, J. Attali, 2005, Diabetes & metabolism.

Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications--the French multicenter study.

P. Valensi, J. Pariés, J. Attali, 2003, Metabolism: clinical and experimental.

[Arterial rigidity and cardiovascular vagosympathetic activity in normotensive and hypertensive obese patients and type 2 diabetics].

M. Brahimi, P. Valensi, P. Platon, 2001, Archives des maladies du coeur et des vaisseaux.

Influence of parasympathetic dysfunction and hyperinsulinemia on the hemodynamic response to an isometric exercise in non-insulin-dependent diabetic patients.

P. Valensi, P. Miossec, J. Pariés, 1998, Metabolism: clinical and experimental.

[Alteration of cardiovascular vagosympathetic control evaluated by spectral analysis of variations of heart rate and blood pressure in obesity].

P. Valensi, M. Chabert, J. Pariés, 1997, Archives des maladies du coeur et des vaisseaux.

[Abnormalities of 24 hour (Holter) ECG monitoring in diabetics: involvement of cardiac autonomic neuropathy and/or insulin therapy].

J. Lanfranchi, P. Valensi, R. Sachs, 1985, Diabete & metabolisme.

Influence of parasympatheitc dysfunction and hyperinsulinemia on the hemodynamic response to an isometric exercise in non—insulin-dependent diabetic patients

P. Valensi, P. Miossec, J. Pariés, 1998 .

Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity

M. Krempf, J. Louvet, J. Joubert, 2003, International Journal of Obesity.

Isotopic test of capillary permeability to albumin in diabetic patients: effects of hypertension, microangiopathy, and duration of diabetes.

P. Valensi, J. Attali, A. Behar, 1987, Metabolism: clinical and experimental.

Haemodynamic response to an isometric exercise test in obese patients: Influence of autonomic dysfunction

P. Valensi, J. Pariés, B. Lormeau, 1999, International Journal of Obesity.

Improving glycaemic control of patients with Type 2 diabetes in a primary care setting: a French application of the Staged Diabetes Management programme

G. Charpentier, I. Durand-zaleski, C. Attali, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.

P. Valensi, J. Vaysse, L. Gattegno, 1999, Diabetes care.

Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.

P. Valensi, J. Attali, C. Giroux, 1997, Journal of diabetes and its complications.

[Diabetes and hemorheology].

P. Valensi, J. Attali, 1990, Diabete & metabolisme.

Red blood cell sodium content in NID diabetic patients with hemorheological abnormalities

B. Marc, J. Attali, F. Zkhiri, 1995 .

Fas/Fas-Ligand pathway is impaired in patients with type 2 diabetes. Influence of hypertension and insulin resistance.

P. Valensi, E. Cosson, G. Feldmann, 2005, Diabetes & metabolism.

TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome

P. Valensi, G. Perret, J. Attali, 1996, Journal of endocrinological investigation.

Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment.

G. Perret, I. Moura, J. Pariés, 1997, Diabetes & metabolism.

Effects of a Purified Micronized Flavonoid Fraction on Capillary Filtration in Diabetic Patients

M. Attalah, J. Attali, A. Behar, 1996, Diabetic medicine : a journal of the British Diabetic Association.

Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events?

P. Valensi, E. Cosson, F. Paycha, 2003, Diabetes & metabolism.